Hepatocellular Carcinoma Arising from Hepatocellular Adenoma in an Elderly Male Patient [0.03%]
老年男性患者肝细胞腺瘤恶变为肝细胞癌一例报告
Manuel Lim,Jong Man Kim,Ji Eun Kwon et al.
Manuel Lim et al.
Hepatocellular adenoma is a benign tumor of the liver occurring predominantly in young women taking oral contraceptives. The malignant transformation of hepatocellular adenoma into hepatocellular carcinoma has rarely been reported. Herein, ...
Case Reports
Journal of liver cancer. 2021 Mar;21(1):87-91. DOI:10.17998/jlc.21.1.87 2021
A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer [0.03%]
一例结肠癌治疗后出现淋巴细胞丰富的肝细胞癌患者病例报告
Jae Won Song,Ho Soo Chun,Jae Seung Lee et al.
Jae Won Song et al.
Hepatocellular carcinoma (HCC) primarily originates in the liver with hepatic differentiation. However, HCCs are not homogenous, and approximately 35% of HCC cases are classified as histopathological variants that present distinct pathologi...
Case Reports
Journal of liver cancer. 2021 Mar;21(1):69-75. DOI:10.17998/jlc.21.1.69 2021
Huge Hepatic Angiomyolipoma Mimicking Low Grade Hepatocellular Carcinoma [0.03%]
巨大肝血管平滑肌脂肪瘤伴发低级别肝细胞癌的诊断陷阱
Hyeo Seong Hwang,Dae Hoon Han
Hyeo Seong Hwang
A 41-year-old man was diagnosed with a huge symptomatic liver mass and was referred to our hospital for liver biopsy and further evaluation. He presented with right upper quadrant tenderness. Enhanced abdominal computed tomography and magne...
Case Reports
Journal of liver cancer. 2021 Mar;21(1):76-80. DOI:10.17998/jlc.21.1.76 2021
Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area [0.03%]
乙肝高发区无肝硬化的丙型肝炎病毒感染相关性肝细胞癌的临床特征及流行病学调查
Jongbeom Shin,Jung Hwan Yu,Young-Joo Jin et al.
Jongbeom Shin et al.
Background/objective: Hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) is rarely observed in patients without liver cirrhosis (LC). We evaluated the incidence and clinical feature of HCV-associated HCC pa...
Update on Pathologic and Radiologic Diagnosis of Combined Hepatocellular-Cholangiocarcinoma [0.03%]
混合型肝细胞胆管癌的病理和影像诊断进展
Hyungjin Rhee,Jae Hyon Park,Young Nyun Park
Hyungjin Rhee
Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a malignant primary liver carcinoma characterized by the unequivocal presence of both hepatocytic and cholangiocytic differentiation within the same tumor. Recent research has highlig...
A Case of Metastatic Melanoma in the Liver Mimicking Hepatocellular Carcinoma [0.03%]
肝转移性黑色素瘤误诊为原发性肝癌一例报告
Jae-Kyoung So,Ji-Yun Hong,Min-Woo Chung et al.
Jae-Kyoung So et al.
The liver is one of the most common sites of metastasis. Although most metastatic liver cancers are hypovascular, some hypervascular metastases, such as those from melanoma, need to be differentiated from hepatocellular carcinoma (HCC) beca...
Case Reports
Journal of liver cancer. 2021 Mar;21(1):92-96. DOI:10.17998/jlc.21.1.92 2021
Rare Case of Pyogenic Brain Abscess after Transarterial Chemoembolization in a Patient with Hepatocellular Carcinoma: Case Report and Literature Review [0.03%]
肝细胞癌患者经动脉化疗栓塞后罕见的脓性脑脓肿病例报告及文献回顾
Jun-Ho Myeong,Jeong-Ju Yoo,Sang Gyune Kim et al.
Jun-Ho Myeong et al.
Transarterial chemoembolization (TACE) is a useful treatment option for hepatocellular carcinoma (HCC). TACE can particularly be used as a treatment for localized HCC, where surgical resection is impossible due to decreased liver function. ...
Case Reports
Journal of liver cancer. 2021 Mar;21(1):81-86. DOI:10.17998/jlc.21.1.81 2021
Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma [0.03%]
RAS 丝裂原活化蛋白激酶信号传导和 RAS 激酶抑制剂作为肝细胞癌的治疗靶点
Hyuk Moon,Simon Weonsang Ro
Hyuk Moon
Hepatocellular carcinoma (HCC) is a high incidence cancer and a major health concern worldwide. Among the many molecular signaling pathways that are dysregulated in HCC, the Ras mitogen-activated protein kinase (Ras/Raf/MAPK) signaling path...
Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm [0.03%]
基于肿瘤特征的巨块型肝细胞癌(≥13cm)术后预后预测模型
Shin Hwang,Ki-Hun Kim,Deok-Bog Moon et al.
Shin Hwang et al.
Background/aims: Multiplication of α-fetoprotein, des-γ-carboxy prothrombin, and tumor volume (ADV score) is a surrogate marker for post-resection prognosis of hepatocellular carcinoma (HCC). This study aimed to validat...
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolization [0.03%]
肝动脉化疗放疗联合选择性肝动脉放射栓塞成功治疗晚期肝细胞癌
Minho Noh,Beom Kyung Kim,Seung Up Kim
Minho Noh
Optimal treatment strategies for patients with advanced hepatocellular carcinoma (HCC) is yet to be determined. Herein, we present a case of advanced HCC with tumor invasion into the right anterior portal vein and right hepatic vein where c...
Case Reports
Journal of liver cancer. 2021 Mar;21(1):97-103. DOI:10.17998/jlc.21.1.97 2021